Clinical trial
The Effect of Intravenous Iron Therapy and Erythropoiesis-stimulation Agent Combination on Renal Transplant Outcomes
NCT05719376 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Intravenous Iron Therapy and Erythropoiesis-stimulation Agent Combination on Renal Transplant Outcomes
- Lead sponsor
- Yonsei University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- February 28, 2023
- Completion date
- June 30, 2026
- Enrollment
- 302 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.